NCT06495281View on ClinicalTrials.gov

Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

October 26, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Type 2 Diabetes Mellitus
Trial Locations (1)

58128

RECRUITING

Chonnam National University Hwasun Hospital, Hwasun

Sponsors

Lead Sponsor

LG Chem
All Listed Sponsors
lead

LG Chem

INDUSTRY

NCT06495281 - Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients | Biotech Hunter | Biotech Hunter